NorthEdge completed the investment in Torbay Pharmaceuticals.

NorthEdge, a private equity firm, completed the investment in Torbay Pharmaceuticals, a pharmaceutical company. Financial terms were not disclosed. “We are delighted to be supporting Emma and the Torbay team on the next phase of their journey. This investment will allow management to accelerate the growth of the business, which will further improve patient outcomes nationally and internationally. We understand the significance of this investment and take our responsibilities of growing the business in a sustainable way very seriously, ensuring Torbay remains an employer of choice in the region and continues to add value to its long-standing customers, as well as the local economy. We look forward to playing our part in growing another business of global significance from the UK regions, working with Emma and the team to build a better business, together,” Ray Stenton, NorthEdge Managing Partner.